skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EBSCO_MEDLINE Complete（医学期刊全文数据库） remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

Sultanik, Philippe ; Mallet, Vincent ; Lagaye, Sylvie ; Casrouge, Armanda ; Dorival, Céline ; Barthe, Yoann ; Fontaine, Hélène ; Hézode, Christophe ; Mottez, Estelle ; Bronowicki, Jean-Pierre ; Carrat, Fabrice ; Theodorou, Ioannis ; Abel, Laurent ; Gayat, Etienne ; Fontanet, Arnaud ; Pol, Stanislas ; Albert, Matthew L.

Liver international, 2015-07, Vol.35 (7), p.1833-1844 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
2
Epigenetic scars of CD8 + T cell exhaustion persist after cure of chronic infection in humans
Epigenetic scars of CD8 + T cell exhaustion persist after cure of chronic infection in humans
Material Type:
Artigo 		Adicionar ao Meu Espaço

Epigenetic scars of CD8 + T cell exhaustion persist after cure of chronic infection in humans

Yates, Kathleen B ; Tonnerre, Pierre ; Martin, Genevieve E ; Gerdemann, Ulrike ; Al Abosy, Rose ; Comstock, Dawn E ; Weiss, Sarah A ; Wolski, David ; Tully, Damien C ; Chung, Raymond T ; Allen, Todd M ; Kim, Arthur Y ; Fidler, Sarah ; Fox, Julie ; Frater, John ; Lauer, Georg M ; Haining, W Nicholas ; Sen, Debattama R

Nature immunology, 2021-08, Vol.22 (8), p.1020-1029 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
COVID-19 Therapeutics for Nonhospitalized Patients
COVID-19 Therapeutics for Nonhospitalized Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

COVID-19 Therapeutics for Nonhospitalized Patients

Gandhi, Rajesh T ; Malani, Preeti N ; del Rio, Carlos

JAMA : the journal of the American Medical Association, 2022-02, Vol.327 (7), p.617-618 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

Citações Citado por
4
Hundreds of COVID trials could provide a deluge of new drugs
Hundreds of COVID trials could provide a deluge of new drugs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hundreds of COVID trials could provide a deluge of new drugs

Ledford, Heidi

Nature (London), 2022-03, Vol.603 (7899), p.25-27 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
5
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Kwo, Paul Y, Dr ; Lawitz, Eric J, MD ; McCone, Jonathan, MD ; Schiff, Eugene R, Prof ; Vierling, John M, Prof ; Pound, David, MD ; Davis, Mitchell N, DO ; Galati, Joseph S, MD ; Gordon, Stuart C, MD ; Ravendhran, Natarajan, MD ; Rossaro, Lorenzo, Prof ; Anderson, Frank H, MD ; Jacobson, Ira M, Prof ; Rubin, Raymond, MD ; Koury, Kenneth, PhD ; Pedicone, Lisa D, PhD ; Brass, Clifford A, MD ; Chaudhri, Eirum, MD ; Albrecht, Janice K, PhD

The Lancet (British edition), 2010-08, Vol.376 (9742), p.705-716 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients

Parums, Dinah V

Medical science monitor, 2022-01, Vol.28, p.e935952-e935952

United States: International Scientific Literature, Inc

Texto completo disponível

Citações Citado por
7
Why scientists are racing to develop more COVID antivirals
Why scientists are racing to develop more COVID antivirals
Material Type:
Artigo 		Adicionar ao Meu Espaço

Why scientists are racing to develop more COVID antivirals

Kozlov, Max

Nature (London), 2022-01, Vol.601 (7894), p.496-496 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
Material Type:
Artigo 		Adicionar ao Meu Espaço

Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management

Heskin, Joseph ; Pallett, Scott J C ; Mughal, Nabeela ; Davies, Gary W ; Moore, Luke S P ; Rayment, Michael ; Jones, Rachael

The Lancet (British edition), 2022-01, Vol.399 (10319), p.21-22 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
The global COVID-19 treatment divide
The global COVID-19 treatment divide
Material Type:
Artigo 		Adicionar ao Meu Espaço

The global COVID-19 treatment divide

Usher, Ann Danaiya

The Lancet (British edition), 2022-02, Vol.399 (10327), p.779-782 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
Material Type:
Artigo 		Adicionar ao Meu Espaço

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence

Zamor, Philippe J ; Brown, Ashley ; Dylla, Douglas E ; Dillon, John F ; Luetkemeyer, Anne F ; Feld, Jordan J ; Mutimer, David ; Ghalib, Reem ; Crown, Eric ; Lovell, Sandra S ; Hu, Yiran ; Moreno, Christophe ; Nelson, David R ; Colombo, Massimo ; Papatheodoridis, Georgios ; Rockstroh, Juergen K ; Skoien, Richard ; Lawitz, Eric ; Jacobson, Ira M

The American journal of gastroenterology, 2021-09, Vol.116 (9), p.1896-1904 [Periódico revisado por pares]

United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (510)
  2. Revistas revisadas por pares (586)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (649)
  2. magazinearticle  (3)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1980  (27)
  2. 1980Até1989  (197)
  3. 1990Até2001  (24)
  4. 2002Até2012  (138)
  5. Após 2012  (268)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (631)
  2. Japonês  (65)
  3. Russo  (9)
  4. Alemão  (6)
  5. Hebraico  (4)
  6. Polonês  (3)
  7. Serbian  (2)
  8. Norueguês  (1)
  9. Português  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.